Paradigm Biocapital Advisors LP

Holdings History for Cidara Therapeutics, Inc. - Common Stock, par value $0.0001 per share (CDTX)

Symbol: CDTX
Investment type: Equity / Common Stock, par value $0.0001 per share
Latest Disclosed Shares Owned: 961,164 shares
Security Ownership %: 3.3%

Shares, Excluding Options vs Price

Value, Excluding Options

Paradigm BioCapital Advisors LP ownership in Cidara Therapeutics, Inc. Common Stock, par value $0.0001 per share (CDTX)

14 Nov 2025 - Paradigm BioCapital Advisors LP has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 961,164 shares of Cidara Therapeutics, Inc. Common Stock, par value $0.0001 per share (CDTX). This represents 3.3% ownership of the company. In their previous filing dated 30 Jul 2025, Paradigm Biocapital Advisors LP had reported owning 1,128,613 shares, indicating a decrease of +15%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Paradigm BioCapital Advisors LP	3.3%	-38%	$92,041,065	961,164	-167,449	-15%	$95.76	13G/A	30 Sep 2025	14 Nov 2025, 16:34
Paradigm BioCapital Advisors LP	5.6%		$54,974,739	1,128,613			$48.71	13G	23 Jul 2025	30 Jul 2025, 16:14

Holdings date	Option	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025		4.5%	-1.2%	$167,780,313	759,565	-201,599	-21%	$220.89	Q4 2025
30 Sep 2025		2.7%	+2.7%	$92,041,065	961,164	+961,164	NEW	$95.76	Q3 2025

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.